Bionanotechnology in Cancer
275,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 1-2 Wochen
payback
138 °P sammeln
  • Gebundenes Buch

The authors couldnâ t see a highly useful book, which can provide very concise but still discussing all fields that related to nano cancer research in diagnosis and Drug delivery. To fill this vacuum, the authors bring forward the book â Bio Nanotechnology in Cancer: Diagnosis and Therapyâ .

Andere Kunden interessierten sich auch für
Produktbeschreibung
The authors couldnâ t see a highly useful book, which can provide very concise but still discussing all fields that related to nano cancer research in diagnosis and Drug delivery. To fill this vacuum, the authors bring forward the book â Bio Nanotechnology in Cancer: Diagnosis and Therapyâ .
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Autorenporträt
D. Sakthi Kumar is deputy director of Bio Nano Electronics Research Centre (BNERC) and professor in the Graduate School of Interdisciplinary New Science, Toyo University, Japan. He is interested in developing bionano devices and nanodrugs to fight cancers, organs on a chip, application of artificial intelligence in the bionano field, biomaterials, scaffolds for implantations, bio/chemical/optical sensors, nanobio imaging materials, quantum dots, and solar cells. Prof. Kumar has published more than 150 peer-reviewed research articles in international journals, has edited several books and published many book chapters, and owns 8 patents. He has delivered many plenary talks, invited talks, and tutorial talks at international seminars. For his work in biopolymers, the Society of Polymer Science, Japan, honored him with the Asia Excellence Award in 2012. Prof. Kumar is also an editorial board member of Scientific Reports. Aswathy Ravindran Girija is a research fellow at Future Industries Research Institute, University of South Australia, Australia. She holds a PhD in life science (specialization in bionano science fusion) from Toyo University, Japan. Before moving to Australia, she was working as a post-doctoral researcher at BNERC. Dr Girija's interdisciplinary research has focused on the development and application of biocompatible nanomaterials for theragnostic (therapeutic and diagnostic) application in cancer nanotechnology. She is an enthusiastic bionano science fusion expert with postdoctoral experience and extensive hands-on skills in nanotechnology (nanomaterials synthesis and characterization), targeted drug delivery in cancer cells, imaging cancer cells with contrast agents, development of nano-nutraceuticals, biomaterials (fabrication of nanofibers by electrospinning for wound healing), and microbial technology.